Tributary Capital Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-31,168
Closed -$7.49M 168
2023
Q2
$7.49M Sell
31,168
-10,328
-25% -$2.15M 0.67% 65
2023
Q1
$7.8M Sell
41,496
-40,397
-49% -$8.35M 0.72% 63
2022
Q4
$17.4M Sell
81,893
-18,196
-18% -$3.64M 1.73% 14
2022
Q3
$15.7M Sell
100,089
-922
-0.9% -$147K 1.65% 17
2022
Q2
$15.1M Buy
101,011
+49,035
+94% +$7.1M 1.5% 29
2022
Q1
$8.5M Buy
51,976
+2,525
+5% +$416K 0.67% 64
2021
Q4
$10.8M Sell
49,451
-80,823
-62% -$16.9M 0.81% 59
2021
Q3
$24.7M Sell
130,274
-1,918
-1% -$350K 1.91% 7
2021
Q2
$23.3M Sell
132,192
-5,954
-4% -$1.03M 1.77% 10
2021
Q1
$22.7M Sell
138,146
-37,063
-21% -$5.67M 1.77% 13
2020
Q4
$24.4M Sell
175,209
-8,666
-5% -$1.09M 1.75% 12
2020
Q3
$20.5M Sell
183,875
-10,257
-5% -$1.19M 1.77% 12
2020
Q2
$18.1M Buy
194,132
+12,677
+7% +$1.08M 1.54% 22
2020
Q1
$13.3M Sell
181,455
-5,573
-3% -$484K 1.36% 28
2019
Q4
$15.7M Sell
187,028
-5,828
-3% -$451K 1.1% 45
2019
Q3
$16.2M Sell
192,856
-5,559
-3% -$420K 1.18% 42
2019
Q2
$13M Buy
+198,415
New +$11.4M 0.91% 53

Other funds holding MEDP

Tributary Capital Management's MEDP Position: Q3 2023 in Review

Tributary Capital Management sold out of Medpace (MEDP) in Q3 2023, closing a stake of 31,168 shares — an estimated $7.49M sold.

Tributary Capital Management first reported a position in MEDP in Q2 2019 and held it in 17 quarters. The position peaked at $24.7M in Q3 2021. 488 funds tracked by Wall St. Rank hold MEDP as of Q3 2023.

  • Tributary Capital Management reported no remaining Medpace position as of Q3 2023 after selling out during the quarter.
  • Tributary Capital Management sold 31,168 Medpace shares in Q3 2023, an estimated $7.49M.
  • Tributary Capital Management first reported a position in Medpace in Q2 2019 and held it in 17 quarters.
  • Tributary Capital Management's Medpace position peaked at $24.7M in Q3 2021.
  • 488 funds tracked by Wall St. Rank held Medpace as of Q3 2023.

Based on Tributary Capital Management's 13F filing for Q3 2023, filed 11 Oct 2023.